|Videos|October 12, 2021

Addressing Influenza in the COVID-19 Era

Author(s)Tina Q. Tan, M.D., FAAP, FIDSA, FDIPS, John J Russell, MD, FAAFP, Stephan Foster, PharmD, FAPhA, FNAP

A group of experts led by Tina Q. Tan, MD, FAAP, FIDSA, FDIPS, discuss how best to address influenza prevention, identification, and treatment in the COVID-19 era and beyond.

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Addressing Influenza in the COVID-19 Era

Related Content

Practice size: How many doctors are in the office?

Maternal mortality; brain implant research; $30M in phony claims for COVID-19 tests – Morning Medical Update

More than 90% of docs feeling burned out: survey

Doctors must have robust online presence to meet today’s patients’ expectations

Responding to patient requests for a second opinion

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Medical Economics

Burnout skyrockets as corporate owners place profits over patients, employed docs say

Medicare Advantage members are losing trust in their plans — and physicians are absorbing the fallout

Most patients view test results before hearing from a physician

Ambient AI is coding for payers, not patients

Single payer? Medicaid reform? Lawmakers debate best ways to cut health care spending